Appoints Justine Heath as New COO / CFO
Melbourne, Feb 6, 2015 AEST (ABN Newswire) - Rhinomed Ltd (
ASX:RNO) is pleased to announce the appointment of Justine Heath as its Chief Operating Officer/Chief Financial Officer effective from today.
Ms. Heath is a Fellow of the Institute of Chartered Accountants, Australia and has more than two decades experience in senior finance and operational roles. Ms. Heath brings considerable executive experience in healthcare and technology development companies and a strong commercial background. She started her career at PWC before working at Santos and then in senior roles at healthcare major Faulding and as COO/CFO at ASX listed Hexima before its privatisation. More recently Ms. Heath was CFO at hearing aid company Blamey Saunders.
In announcing Ms. Heath's appointment, CEO Michael Johnson said, "Justine's appointment comes at an important time in Rhinomed's development. With a clear focus on expanding the presence of our two OTC products - Turbine and Mute - and the advancing trial program in Sleep Apnea and Drug Delivery Justine's financial, governance and operational experience adds to the capability of the company at a critically important time of the company's growth. We are thrilled to be able to attract someone of her caliber to the company."
About Rhinomed Limited
Rhinomed Limited (ASX:RNO) is a Melbourne based technology firm with a focus on nasal, respiratory and breathing management technologies. The company is seeking to monetise applications of its technology portfolio in the Sport, Sleep, Wellbeing and Drug Delivery markets. For more information, go to www.rhinomed.global
Follow the Turbine on Twitter at @theturbinecom
Follow Mute Snoring on Twitter at @mutesnoring
| ||
|
